Cargando…

3,3′-Diindolylmethane improves antitumor immune responses of PD-1 blockade via inhibiting myeloid-derived suppressor cells

BACKGROUND: Immune checkpoint inhibitors that target programmed cell death protein 1 (PD-1) have obtained encouraging results, but a fraction of tumor patients failed to respond to anti-PD-1 treatment due to the existence of multiple immune suppressive elements such as myeloid-derived suppressor cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Qi, Xiao, Lin, Cui, Zhiying, Yang, Yaping, Ma, Junting, Huang, Zhen, Zhang, Junfeng, Chen, Jiangning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245307/
https://www.ncbi.nlm.nih.gov/pubmed/35773674
http://dx.doi.org/10.1186/s13020-022-00638-z
_version_ 1784738716737077248
author Sun, Qi
Xiao, Lin
Cui, Zhiying
Yang, Yaping
Ma, Junting
Huang, Zhen
Zhang, Junfeng
Chen, Jiangning
author_facet Sun, Qi
Xiao, Lin
Cui, Zhiying
Yang, Yaping
Ma, Junting
Huang, Zhen
Zhang, Junfeng
Chen, Jiangning
author_sort Sun, Qi
collection PubMed
description BACKGROUND: Immune checkpoint inhibitors that target programmed cell death protein 1 (PD-1) have obtained encouraging results, but a fraction of tumor patients failed to respond to anti-PD-1 treatment due to the existence of multiple immune suppressive elements such as myeloid-derived suppressor cells (MDSCs). Traditional Chinese medicine or natural products from medicinal plants could enhance immunity and may be helpful for cancer immunotherapy. As a digestive metabolite from cruciferous plants, 3,3′-diindolylmethane (DIM) has been widely used in chemotherapy, but its influence on cancer immunotherapy remains unclear. Here we investigate the function of DIM on MDSCs and examine the therapeutic effects of DIM in conjunction with PD-1 antibody against mouse tumors. METHODS: Flow cytometry analysis, Western blot analysis and qRT-PCR assay were used to examine the inhibitory effects and mechanisms of DIM on MDSCs in vitro and in vivo. The therapeutic effects of DIM on cancer immunotherapy by PD-1 antibody were evaluated in mouse models of breast cancer and melanoma tumor. RESULTS: DIM exerted the inhibitory effect on MDSCs via downregulating miR-21 level and subsequently activating PTEN/PIAS3-STAT3 pathways. Adoptive transfer of MDSCs impaired the therapeutic effects of DIM, indicating that the antitumor activity of DIM might be due to the suppression of MDSCs. Furthermore, in mouse models of breast cancer and melanoma tumor, the addition of DIM can enhance the therapeutic effect of PD-1 antibody through promoting T cells responses, and thereby inhibiting tumor growth. CONCLUSIONS: Overall, the strategy based on the combination treatment of anti-PD-1 antibody and DIM may provide a new approach for cancer immunotherapy. Cruciferae plants-rich diet which contains high amount of DIM precursor may be beneficial for cancer patients that undergo the anti-PD-1 treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13020-022-00638-z.
format Online
Article
Text
id pubmed-9245307
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92453072022-07-01 3,3′-Diindolylmethane improves antitumor immune responses of PD-1 blockade via inhibiting myeloid-derived suppressor cells Sun, Qi Xiao, Lin Cui, Zhiying Yang, Yaping Ma, Junting Huang, Zhen Zhang, Junfeng Chen, Jiangning Chin Med Research BACKGROUND: Immune checkpoint inhibitors that target programmed cell death protein 1 (PD-1) have obtained encouraging results, but a fraction of tumor patients failed to respond to anti-PD-1 treatment due to the existence of multiple immune suppressive elements such as myeloid-derived suppressor cells (MDSCs). Traditional Chinese medicine or natural products from medicinal plants could enhance immunity and may be helpful for cancer immunotherapy. As a digestive metabolite from cruciferous plants, 3,3′-diindolylmethane (DIM) has been widely used in chemotherapy, but its influence on cancer immunotherapy remains unclear. Here we investigate the function of DIM on MDSCs and examine the therapeutic effects of DIM in conjunction with PD-1 antibody against mouse tumors. METHODS: Flow cytometry analysis, Western blot analysis and qRT-PCR assay were used to examine the inhibitory effects and mechanisms of DIM on MDSCs in vitro and in vivo. The therapeutic effects of DIM on cancer immunotherapy by PD-1 antibody were evaluated in mouse models of breast cancer and melanoma tumor. RESULTS: DIM exerted the inhibitory effect on MDSCs via downregulating miR-21 level and subsequently activating PTEN/PIAS3-STAT3 pathways. Adoptive transfer of MDSCs impaired the therapeutic effects of DIM, indicating that the antitumor activity of DIM might be due to the suppression of MDSCs. Furthermore, in mouse models of breast cancer and melanoma tumor, the addition of DIM can enhance the therapeutic effect of PD-1 antibody through promoting T cells responses, and thereby inhibiting tumor growth. CONCLUSIONS: Overall, the strategy based on the combination treatment of anti-PD-1 antibody and DIM may provide a new approach for cancer immunotherapy. Cruciferae plants-rich diet which contains high amount of DIM precursor may be beneficial for cancer patients that undergo the anti-PD-1 treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13020-022-00638-z. BioMed Central 2022-06-30 /pmc/articles/PMC9245307/ /pubmed/35773674 http://dx.doi.org/10.1186/s13020-022-00638-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Sun, Qi
Xiao, Lin
Cui, Zhiying
Yang, Yaping
Ma, Junting
Huang, Zhen
Zhang, Junfeng
Chen, Jiangning
3,3′-Diindolylmethane improves antitumor immune responses of PD-1 blockade via inhibiting myeloid-derived suppressor cells
title 3,3′-Diindolylmethane improves antitumor immune responses of PD-1 blockade via inhibiting myeloid-derived suppressor cells
title_full 3,3′-Diindolylmethane improves antitumor immune responses of PD-1 blockade via inhibiting myeloid-derived suppressor cells
title_fullStr 3,3′-Diindolylmethane improves antitumor immune responses of PD-1 blockade via inhibiting myeloid-derived suppressor cells
title_full_unstemmed 3,3′-Diindolylmethane improves antitumor immune responses of PD-1 blockade via inhibiting myeloid-derived suppressor cells
title_short 3,3′-Diindolylmethane improves antitumor immune responses of PD-1 blockade via inhibiting myeloid-derived suppressor cells
title_sort 3,3′-diindolylmethane improves antitumor immune responses of pd-1 blockade via inhibiting myeloid-derived suppressor cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245307/
https://www.ncbi.nlm.nih.gov/pubmed/35773674
http://dx.doi.org/10.1186/s13020-022-00638-z
work_keys_str_mv AT sunqi 33diindolylmethaneimprovesantitumorimmuneresponsesofpd1blockadeviainhibitingmyeloidderivedsuppressorcells
AT xiaolin 33diindolylmethaneimprovesantitumorimmuneresponsesofpd1blockadeviainhibitingmyeloidderivedsuppressorcells
AT cuizhiying 33diindolylmethaneimprovesantitumorimmuneresponsesofpd1blockadeviainhibitingmyeloidderivedsuppressorcells
AT yangyaping 33diindolylmethaneimprovesantitumorimmuneresponsesofpd1blockadeviainhibitingmyeloidderivedsuppressorcells
AT majunting 33diindolylmethaneimprovesantitumorimmuneresponsesofpd1blockadeviainhibitingmyeloidderivedsuppressorcells
AT huangzhen 33diindolylmethaneimprovesantitumorimmuneresponsesofpd1blockadeviainhibitingmyeloidderivedsuppressorcells
AT zhangjunfeng 33diindolylmethaneimprovesantitumorimmuneresponsesofpd1blockadeviainhibitingmyeloidderivedsuppressorcells
AT chenjiangning 33diindolylmethaneimprovesantitumorimmuneresponsesofpd1blockadeviainhibitingmyeloidderivedsuppressorcells